NL-OMON52316招募中2 期
The Dutch Parkinson GBA Ambroxol trial (DUPARG-AMBROXOL): A randomised, double-blind, placebo-controlled, single-center trial with Ambroxol in Parkinson patients with a GBA mutation - The Dutch Parkinson GBA Ambroxol trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Diagnosis of Parkinson*s disease, according to Movement Disorders Society
- •(MDS) criteria <10 years
- •- PD patients carrying a GBA1 mutation
- •- Willingness to cooperate and sign written informed consent
- •- Willing and able to self-administer oral ambroxol medication
排除标准
- •- The refusal to be informed about an unforeseen clinical finding
- •- Pregnant or breast feeding women
- •- Use of an implanted Deep Brain Stimulation (DBS) system
- •- MRI imcompatible implants in the body
研究者
相似试验
招募中
1 期
The Dutch Parkinson GBA Ambroxol trialEUCTR2021-001833-38-NLniversity Medical Center Groningen80
招募中
不适用
The Dutch Parkinson-GBA Cohort Study (DUPARG) Cognitive and cholinergic function analysis in Dutch Parkinson*s patients with GBA variations.Parkinson's diseaseParkinson10028037NL-OMON50798niversitair Medisch Centrum Groningen205
招募中
3 期
Ambroxol to Slow Progression in Parkinson DiseaseParkinson DiseaseNCT05778617University College, London330
招募中
2 期
GRoningen Early-PD Ambroxol TreatmentParkinsonParkinson DiseaseNCT05830396University Medical Center Groningen80
招募中
不适用
The Dutch Parkinson and Cognition Study (DUPARC): A prospective study on cognitive pathology in de novo Parkinson*s diseaseParkinson10028037Parkinson's diseaseNL-OMON50521niversitair Medisch Centrum Groningen455